OvaScience Reports Fourth Quarter and Year End 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4
March 17, 2015 6:35 AM EDTLeerink Partners analyst Gena Wang reiterated an Outperform rating and $56 price target on OvaScience (NASDAQ: OVAS) following Q4 results, noting the AUGMENT commercial launch is on track, with pipeline assets providing upside.
Wang commented, "While no commercial cycles reported in 4Q:14,... More
Ovascience (OVAS) Misses Q4 EPS by 20c
March 16, 2015 4:34 PM EDTOvascience (NASDAQ: OVAS) reported Q4 EPS of ($0.79), $0.20 worse than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Ovascience (OVAS) click here.
... More